Indegene Expands Consulting Practice for Life Sciences Growth

Indegene today unveiled its ambitious expansion of the Consulting Practice, reaffirming its ongoing commitment to enable life sciences organizations to navigate value and risk in large transformation efforts, in a complex, technology-driven world.

As life sciences companies want partners who can do more than just strategy to create real-world impact, Indegene's integrated consulting methodology offers strategic thinking along with implementation support for transformation.

This expansion represents Indegene's continual commitment to its clients - speed, impact, and accountability - across all value streams. Indegene has appointed Gobin Chandra as the Head of the Integrated Consulting Practice and will begin to lead the consulting business into its next growth phase.

Also Read: Advanced Formulation Technologies Streamlining Global Pharma Innovation

Gobin, who currently leads Indegene's Europe region, has significant transformation advisory experience at Bain & Company and will develop the consulting charter across strategy and transformation services.

During the past ten years, Indegene has gradually built its consulting capabilities through related acquisitions and by expanding organically. In this regard, the 2020 acquisition of DT Consulting helped bolster Indegene’s own capabilities in terms of customer experience and agile digital transformation. In addition to this acquisition, Indegene has further developed its transformation consulting capacity to support its clients with its recent acquisition of WARN & Co., a UK-based firm that managed large-scale change processes for organizations.

With these new strengths, Indegene has emerged as a new and stronger strategic partner that will enable global life sciences organizations to respond to changing market needs and enable new sustainability-oriented transformation of their businesses.